CARSGEN THERAPEUTICS HLDGS LTD
(HKEX: 2171)
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The firm focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company was founded by Zong Hai Li and Hua Mao Wang on February 9, 2018, and is headquartered in Shanghai, China.
15.490 -
-0.400
(-2.52%)
Range
15.390 - 16.210
(5.33%)
Open
16.210
Previous Close
15.890
Bid Price
15.450
Bid Volume
('000)
1
Ask Price
15.500
Ask Volume
('000)
7
Volume
('000)
968
Value
15,089,415
Remark
-
Delayed prices. Updated at 30 Jan 2026 00:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
